The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?
Endocr Rev
; 13(2): 146-63, 1992 May.
Article
em En
| MEDLINE
| ID: mdl-1618161
Palavras-chave
Americas; Animals, Laboratory; Biology; Breast Cancer; Cancer; Clinical Research; Clinical Trials; Critique; Developed Countries; Diseases; Endocrine System; Ethics; Hormone Antagonists; Hormone Receptors; Hormones; Literature Review; Membrane Proteins; Neoplasms; North America; Northern America; Obstacles; Organization And Administration; Physiology; Progestational Hormones; Progesterone; Research Methodology; Ru-486--beneficial effects; Ru-486--pharmacodynamics; Ru-486--side effects; Treatment; United States
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Progesterona
/
Neoplasias da Mama
/
Mifepristona
Tipo de estudo:
Systematic_reviews
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Ano de publicação:
1992
Tipo de documento:
Article